Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.

Identifieur interne : 003A34 ( Main/Exploration ); précédent : 003A33; suivant : 003A35

Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.

Auteurs : A. Szczeklik ; R J Gryglewski ; G. Czerniawska-Mysik

Source :

RBID : ISTEX:55BBC17D7829E4155F29EFBB9D5DE789E9881B5A

English descriptors

Abstract

Eleven patients with asthma and aspirin hypersensitivity have been challenged with eight non-steroidal anti-inflammatory drugs. Each drug was given by mouth in at least three different doses and the patients' symptoms and peak expiratory flow (PEF) rates were observed over a three-hour period. Indomethacin 5 mg caused bronchoconstriction in all patients. Therapeutic doses of mefenamic or flufenamic acid caused bronchoconstriction in most patients. Phenylbutazone 200-400 mg induced a moderate fall in PEF. There were no reactions to therapeutic doses of salicylamide, paracetamol, benzydamine, and chloroquine. Microsomal prostaglandin synthetase, activity was inhibited by aspirin, indomethacin, mefenamic acid, flufenamic acid, and phenylbutazone. The other four drugs had no inhibitory effect. We suggest that precipitation of attacks in asthmatic patients hypersensitive to certain anti-inflammatory drugs is related to drug's ability to inhibit prostaglandin biosynthesis.

Url:
DOI: 10.1136/bmj.1.5949.67


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.</title>
<author>
<name sortKey="Szczeklik, A" sort="Szczeklik, A" uniqKey="Szczeklik A" first="A" last="Szczeklik">A. Szczeklik</name>
</author>
<author>
<name sortKey="Gryglewski, R J" sort="Gryglewski, R J" uniqKey="Gryglewski R" first="R J" last="Gryglewski">R J Gryglewski</name>
</author>
<author>
<name sortKey="Czerniawska Mysik, G" sort="Czerniawska Mysik, G" uniqKey="Czerniawska Mysik G" first="G" last="Czerniawska-Mysik">G. Czerniawska-Mysik</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:55BBC17D7829E4155F29EFBB9D5DE789E9881B5A</idno>
<date when="1975" year="1975">1975</date>
<idno type="doi">10.1136/bmj.1.5949.67</idno>
<idno type="url">https://api.istex.fr/ark:/67375/NVC-KCH4VSTT-W/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001934</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001934</idno>
<idno type="wicri:Area/Istex/Curation">001934</idno>
<idno type="wicri:Area/Istex/Checkpoint">002781</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002781</idno>
<idno type="wicri:doubleKey">0007-1447:1975:Szczeklik A:relationship:of:inhibition</idno>
<idno type="wicri:Area/Main/Merge">003B14</idno>
<idno type="wicri:Area/Main/Curation">003A34</idno>
<idno type="wicri:Area/Main/Exploration">003A34</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.</title>
<author>
<name sortKey="Szczeklik, A" sort="Szczeklik, A" uniqKey="Szczeklik A" first="A" last="Szczeklik">A. Szczeklik</name>
</author>
<author>
<name sortKey="Gryglewski, R J" sort="Gryglewski, R J" uniqKey="Gryglewski R" first="R J" last="Gryglewski">R J Gryglewski</name>
</author>
<author>
<name sortKey="Czerniawska Mysik, G" sort="Czerniawska Mysik, G" uniqKey="Czerniawska Mysik G" first="G" last="Czerniawska-Mysik">G. Czerniawska-Mysik</name>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">British Medical Journal</title>
<title level="j" type="abbrev">Br Med J</title>
<idno type="ISSN">0007-1447</idno>
<idno type="eISSN">1468-5833</idno>
<imprint>
<publisher>British Medical Journal Publishing Group</publisher>
<date type="published" when="1975-01-11">1975-01-11</date>
<biblScope unit="volume">1</biblScope>
<biblScope unit="issue">5949</biblScope>
<biblScope unit="page" from="67">67</biblScope>
</imprint>
<idno type="ISSN">0007-1447</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0007-1447</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Adverse reactions</term>
<term>Angioneurotic oedema</term>
<term>Antiinflammatory drugs</term>
<term>Arachidonic acid</term>
<term>Aspirin</term>
<term>Aspirin hypersensitivity</term>
<term>Aspirinsensitive patients</term>
<term>Asthma</term>
<term>Asthma attacks</term>
<term>Asthmatic</term>
<term>Asthmatic attacks</term>
<term>Asthmatic patients</term>
<term>Benzydamine</term>
<term>Biosynthesis</term>
<term>Clinical immunology</term>
<term>Dos</term>
<term>Enzymic activity</term>
<term>Flufenamic</term>
<term>Flufenamic acid</term>
<term>Indomethacin</term>
<term>Inhibitory action</term>
<term>Internal medicine</term>
<term>Mefenamic</term>
<term>Mefenamic acid</term>
<term>Mmol phosphate buffer</term>
<term>Nasal polyps</term>
<term>Paracetamol</term>
<term>Peak expiratory flow</term>
<term>Phenylbutazone</term>
<term>Prostaglandin</term>
<term>Prostaglandin biosynthesis</term>
<term>Rhinorrhoea</term>
<term>Salicylamide</term>
<term>Therapeutic doses</term>
<term>Untoward reactions</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Eleven patients with asthma and aspirin hypersensitivity have been challenged with eight non-steroidal anti-inflammatory drugs. Each drug was given by mouth in at least three different doses and the patients' symptoms and peak expiratory flow (PEF) rates were observed over a three-hour period. Indomethacin 5 mg caused bronchoconstriction in all patients. Therapeutic doses of mefenamic or flufenamic acid caused bronchoconstriction in most patients. Phenylbutazone 200-400 mg induced a moderate fall in PEF. There were no reactions to therapeutic doses of salicylamide, paracetamol, benzydamine, and chloroquine. Microsomal prostaglandin synthetase, activity was inhibited by aspirin, indomethacin, mefenamic acid, flufenamic acid, and phenylbutazone. The other four drugs had no inhibitory effect. We suggest that precipitation of attacks in asthmatic patients hypersensitive to certain anti-inflammatory drugs is related to drug's ability to inhibit prostaglandin biosynthesis.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Czerniawska Mysik, G" sort="Czerniawska Mysik, G" uniqKey="Czerniawska Mysik G" first="G" last="Czerniawska-Mysik">G. Czerniawska-Mysik</name>
<name sortKey="Gryglewski, R J" sort="Gryglewski, R J" uniqKey="Gryglewski R" first="R J" last="Gryglewski">R J Gryglewski</name>
<name sortKey="Szczeklik, A" sort="Szczeklik, A" uniqKey="Szczeklik A" first="A" last="Szczeklik">A. Szczeklik</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A34 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A34 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:55BBC17D7829E4155F29EFBB9D5DE789E9881B5A
   |texte=   Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients.
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021